RLX (RLX) Q1 2026 Earnings Call Transcript

RLX Technologies reported Q1 2026 net revenue of RMB 1.59 billion, up 96.2% year over year and 38.9% sequentially, with non-GAAP operating margin expanding to 19.6% and non-GAAP net income rising to RMB 357.3 million. International business contributed over 70% of revenue, supported by European expansion, a new integrated Nexus facility, and early entry into two new markets in Southeast Asia and Europe. Management framed the U.K. generational smoking ban and China export policy changes as net tailwinds or manageable disruptions, while maintaining a cautious stance on M&A and heated tobacco investment.

Analysis

The market is likely underestimating how much of RLX’s step-up is structural rather than cyclical. A revenue mix now dominated by overseas channels means the company is no longer a pure China-policy beta; it is increasingly a regulatory arbitrage story where stricter enforcement in the U.K. and parts of Europe actually improves the economics of licensed incumbents by clearing out smaller noncompliant brands. That creates a second-order benefit: not just volume share gains, but lower customer acquisition friction and better distributor economics as the channel consolidates.

The bigger medium-term margin lever is manufacturing control. Nexus and the new warehouse footprint suggest RLX is moving from a license/distribution model toward an integrated platform with better gross margin durability and less IP leakage; that should matter most over the next 2-4 quarters as overseas scale ramps and product mix shifts toward higher-value SKUs. The sequential cash decline looks like capital allocation noise, not stress, but it does reduce optionality if Europe requires more working capital than management is implying.

The main risk is that the current narrative is getting a lot of help from one-off timing effects: export-policy front-loading, acquisition accretion, and a favorable read-through from U.K. regulation. If those benefits fade faster than the company can convert new markets into repeatable sell-through, the growth rate can decelerate sharply even while margins hold up. In that scenario, the stock’s multiple would be vulnerable because the market is paying for a multi-year international compounding story, not a one-quarter beat.

Consensus is probably also too relaxed about the U.S. non-entry as a non-event. Staying out of the U.S. preserves capital and avoids regulatory risk, but it also means RLX’s investable thesis hinges on a smaller set of geographies where policy swings and excise schemes can move sentiment quickly. The right way to think about this name is not as a broad consumer growth compounder, but as a high-beta beneficiary of regulatory formalization in select ex-U.S. markets.

Key Decisions for Investors

• Go long RLX on pullbacks over the next 1-3 weeks if the stock fades the headline beat; use a 6-12 month horizon and target a re-rating if Europe ramps without margin giveback. Risk/reward favors upside as long as overseas gross margin stays above 30% and operating margin remains near current levels.
• Pair trade: long RLX / short a basket of smaller unlicensed nicotine or vape competitors in Europe and the U.K. over 3-6 months. The thesis is that regulation and licensing costs will compress weaker players faster than RLX’s scale-driven channel expansion.
• Buy a small RLX call spread 3-6 months out, ideally on weakness after the initial post-earnings move. This expresses upside from regulatory tailwinds and manufacturing leverage while capping premium at risk if the one-off revenue boost rolls off quickly.
• If you already own RLX, hedge with a trailing stop or 15%-20% trim into strength above the next catalyst window, because the next downside leg would likely come from normalization of export-related timing and any slower-than-expected Europe sell-through.
• Do not chase the stock after an up-gap; wait for confirmation that the new warehouse, channel expansion, and modern oral ramp are producing repeatable quarterly unit growth. The cleanest entry is after the market tests whether the beat was structural or timing-driven.